IEFM
EW icon

IQ EQ Fund Management’s Edwards Lifesciences EW Stock Holding History

IQ EQ Fund Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,422
Closed -$501K – 236
2021
Q3 		$501K Hold
4,422
– – 0.08% 191
2021
Q2 		$458K Hold
4,422
– – 0.07% 194
2021
Q1 		$370K Buy
4,422
+301
+7% +$25.4K 0.07% 199
2020
Q4 		$376K Sell
4,121
-304
-7% -$25.2K 0.09% 171
2020
Q3 		$353K Hold
4,425
– – 0.11% 155
2020
Q2 		$306K Hold
4,425
– – 0.1% 149
2020
Q1 		$278K Hold
4,425
– – 0.11% 115
2019
Q4 		$344K Sell
4,425
-921
-17% -$71.9K 0.11% 118
2019
Q3 		$392K Hold
5,346
– – 0.13% 118
2019
Q2 		$329K Buy
+5,346
New +$323K 0.11% 127

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IQ EQ Fund Management's EW Position: Q4 2021 in Review

IQ EQ Fund Management sold out of Edwards Lifesciences (EW) in Q4 2021, closing a stake of 4,422 shares — an estimated $501K sold.

IQ EQ Fund Management first reported a position in EW in Q2 2019 and held it in 10 quarters. The position peaked at $501K in Q3 2021. 1,319 funds tracked by Wall St. Rank hold EW as of Q4 2021.

  • IQ EQ Fund Management reported no remaining Edwards Lifesciences position as of Q4 2021 after selling out during the quarter.
  • IQ EQ Fund Management sold 4,422 Edwards Lifesciences shares in Q4 2021, an estimated $501K.
  • IQ EQ Fund Management first reported a position in Edwards Lifesciences in Q2 2019 and held it in 10 quarters.
  • IQ EQ Fund Management's Edwards Lifesciences position peaked at $501K in Q3 2021.
  • 1,319 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2021.

Based on IQ EQ Fund Management's 13F filing for Q4 2021, filed 2 Feb 2022.